ARTIVION INC (NYSE: AORT)

NYSE: AORT (Artivion, Inc.)

Kemas kini terakhir: 2 hari lalu, 2:45PM

-0.27 (-0.93%)

Tambah ke senarai pantauan

Harga / Pendapatan (P/E Ke hadapan)	476.19
Harga / Jualan (P/S)	3.12
Harga / Buku (P/B)	4.64

Julat 52 Minggu	21.97 (-23%) — 32.33 (12%)
Tarikh Pendapatan	6 Aug 2025 - 11 Aug 2025

Arah Aliran Pasaran

AISkor Stockmoo

1.5

Saham Serupa

Stok	Modal Pasaran	DY	P/E (TTM)	P/B
AORT	1 B	-	-	4.64
PEN	10 B	-	237.05	9.48
GMED	8 B	-	44.16	2.01
GKOS	5 B	-	-	6.64
INSP	4 B	-	85.35	6.16
ITGR	4 B	-	55.02	2.61

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company’s products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
Sektor	Healthcare
Industri	Medical Devices
Gaya Pelaburan	Small Growth
% Dimiliki oleh Orang Dalam	5.07%
% Dimiliki oleh Institusi	91.04%

Pemilikan

Nama	Tarikh	Syer Dipegang
Perceptive Advisors Llc	31 Mar 2025	2,793,703
Juniper Investment Company, Llc	31 Mar 2025	2,098,164
Next Century Growth Investors Llc	31 Mar 2025	1,022,775

Syarikat	Tarikh	Harga Sasaran	Panggilan	Harga @ Panggilan
JMP Securities	06 May 2025	33.00 (14.66%)	Beli	27.42
Needham	06 May 2025	32.00 (11.19%)	Beli	27.42

Tiada data dalam julat masa ini.

Tarikh	Jenis	Butiran
03 Jun 2025	Pengumuman	Artivion to Participate in Upcoming Investor Conferences
28 May 2025	Pengumuman	Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock
14 May 2025	Pengumuman	Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock
05 May 2025	Pengumuman	Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting
05 May 2025	Pengumuman	Artivion Reports First Quarter 2025 Financial Results
21 Apr 2025	Pengumuman	Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results

Purata Hasil Dividen 5T

0.00%

Tarikh EX	Tarikh Pengumuman	Tarikh Pembayaran	Perincian
09 Dec 2015	22 Oct 2015	18 Dec 2015	0.03 Tunai
09 Sep 2015	22 Jul 2015	18 Sep 2015	0.03 Tunai
10 Jun 2015	21 May 2015	19 Jun 2015	0.03 Tunai
11 Mar 2015	13 Feb 2015	20 Mar 2015	0.03 Tunai
10 Dec 2014	23 Oct 2014	19 Dec 2014	0.03 Tunai
10 Sep 2014	30 Jul 2014	19 Sep 2014	0.03 Tunai
11 Jun 2014	22 May 2014	20 Jun 2014	0.03 Tunai
12 Mar 2014	19 Feb 2014	21 Mar 2014	0.0275 Tunai
11 Dec 2013	21 Nov 2013	20 Dec 2013	0.0275 Tunai
11 Sep 2013	21 Aug 2013	20 Sep 2013	0.0275 Tunai
12 Jun 2013	28 May 2013	21 Jun 2013	0.0275 Tunai
12 Mar 2013	13 Feb 2013	21 Mar 2013	0.025 Tunai
12 Dec 2012	19 Nov 2012	21 Dec 2012	0.025 Tunai
12 Sep 2012	21 Aug 2012	21 Sep 2012	0.025 Tunai
Papar semua

Hasil Dividen Tahunan

Tahun	Dividen Tahunan ($)	Kekerapan/Tahun	Hasil %
2015	0.120	4	1.11
2014	0.118	4	1.04
2013	0.108	4	0.97
2012	0.050	2	0.80

Portfolio

AI Templat

Peringatan harga anda

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Tiada saham yang memenuhi kriteria anda

Margin Keuntungan	-3.44%
Margin Operasi (TTM)	3.96%
EPS Cair (TTM)	-0.320
Pertumbuhan Hasil Suku Tahunan (YOY)	3.90%

Jumlah Hutang/Ekuiti (D/E MRQ)	131.16%
Nisbah Semasa (MRQ)	4.34
Aliran Tunai Operasi (OCF TTM)	22.24 M
Aliran Tunai Bebas Leveraj (LFCF TTM)	2.33 M

Pulangan Atas Aset (ROA TTM)	2.21%
Pulangan Atas Ekuiti (ROE TTM)	-4.79%